Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengming Jin

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal for Immunotherapy of Cancer|November 28, 2025
Neutrophil extracellular traps-STC1 positive feedback loop promotes immune evasion and metastasis in bladder cancerTingting Cai, Tao Feng, Wei Zhang, et al.
Journal for Immunotherapy of Cancer|March 12, 2026
Dual regulation of CXCR6<sup>+</sup>CD8<sup>+</sup> T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progressionZhang Xingming, Jianhua Wang, Mierxiati Abudurexiti, et al.
International Urology and Nephrology|September 26, 2019
Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasisShengming Jin, Junjie Wang, Yijun Shen, et al.
International Journal of Cancer|October 22, 2020
Identification of a methylation panel aid in risk stratification in node-positive penile squamous cell carcinomaWeijie Gu, Fangning Wan, Jun Chen, et al.
JCO Precision Oncology|July 25, 2025
Genomic Landscape and Clinical Relevance in Chinese Patients With Upper Tract Urothelial CarcinomaZhi Shang, Jian Pan, Shanshan Wang, et al.
Molecular Oncology|August 16, 2023
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparityYu Wei, Tingwei Zhang, Beihe Wang, et al.
Annals of Surgical Oncology|January 9, 2022
Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer PatientsShengming Jin, Han Zeng, Zhaopei Liu, et al.
Med (New York, N.Y.)|August 16, 2024
Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancerJian Pan, Junlong Wu, Beihe Wang, et al.
Cancer Immunology, Immunotherapy : CII|December 15, 2022
Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patientsBangwei Fang, Yu Wei, Hao Zeng, et al.
Frontiers in Oncology|December 28, 2020
Prognostic Value of Local Treatment in Prostate Cancer Patients With Different Metastatic Sites: A Population Based Retrospective StudyShengming Jin, Jiaming Wei, Junjie Wang, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|November 28, 2025
Neutrophil extracellular traps-STC1 positive feedback loop promotes immune evasion and metastasis in bladder cancerTingting Cai, Tao Feng, Wei Zhang, et al.
Journal for Immunotherapy of Cancer|March 12, 2026
Dual regulation of CXCR6<sup>+</sup>CD8<sup>+</sup> T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progressionZhang Xingming, Jianhua Wang, Mierxiati Abudurexiti, et al.
International Urology and Nephrology|September 26, 2019
Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasisShengming Jin, Junjie Wang, Yijun Shen, et al.
International Journal of Cancer|October 22, 2020
Identification of a methylation panel aid in risk stratification in node-positive penile squamous cell carcinomaWeijie Gu, Fangning Wan, Jun Chen, et al.
JCO Precision Oncology|July 25, 2025
Genomic Landscape and Clinical Relevance in Chinese Patients With Upper Tract Urothelial CarcinomaZhi Shang, Jian Pan, Shanshan Wang, et al.
Molecular Oncology|August 16, 2023
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparityYu Wei, Tingwei Zhang, Beihe Wang, et al.
Annals of Surgical Oncology|January 9, 2022
Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer PatientsShengming Jin, Han Zeng, Zhaopei Liu, et al.
Med (New York, N.Y.)|August 16, 2024
Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancerJian Pan, Junlong Wu, Beihe Wang, et al.
Cancer Immunology, Immunotherapy : CII|December 15, 2022
Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patientsBangwei Fang, Yu Wei, Hao Zeng, et al.
Frontiers in Oncology|December 28, 2020
Prognostic Value of Local Treatment in Prostate Cancer Patients With Different Metastatic Sites: A Population Based Retrospective StudyShengming Jin, Jiaming Wei, Junjie Wang, et al.
Pageof 6